D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IMDX holding history
Insight Molecular Diagnostics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMDX overviewAll 13F holders of IMDXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −38,291−100.0% | Sold out | Holders |
| Q3 2022 | 38,291 | $28.0K | <0.1% | −43,805−53.4% | Reduced | Holders |
| Q2 2022 | 82,096 | $74.0K | <0.1% | −163,754−66.6% | Reduced | Holders |
| Q1 2022 | 245,850 | $366.0K | <0.1% | −81,240−24.8% | Reduced | Holders |
| Q4 2021 | 327,090 | $710.0K | <0.1% | +122,463+59.8% | Added | Holders |
| Q3 2021 | 204,627 | $729.0K | <0.1% | +167,771+455.2% | Added | Holders |
| Q2 2021 | 36,856 | $212.0K | <0.1% | +36,856 | New | Holders |